Inhaltsbereich
| 21411 Einträge | « ‹ 863, 864, 865, 866, 867, 868, 869, 870, 871, 872, 873, 874, 875, 876, 877, 878, 879, 880, 881 › » |
Seite 872 / 1071
 Druckansicht
|
| Diagnosis, treatment, and use of intravenous iron for chemotherapy-induced anemia in Europe. |
| Aapro MS, Beguin Y, Bokemeyer C, Glaspy JA, Hedenus M, Littlewood TJ, Ludwig H, Osterborg A, Rzychon B, Mitchell D |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Jan 1. pii: 10.1200/jco.2011.29.15_suppl.e19557 |
| PMID: 28020994 |
| An international, randomized, placebo-controlled, double-blind phase III study (MONET1) of motesanib plus carboplatin/paclitaxel (C/P) in patients with advanced nonsquamous non-small cell lung cancer (NSCLC). |
| Scagliotti G, Vynnychenko I, Ichinose Y, Park K, Kubota K, Blackhall FH, Pirker R, Galiulin R, Ciuleanu T, Sydorenko O, Dediu M, Papai-Szekely Z, Martinez Banaclocha N, McCoy S, Yao B, Hei YJ, Spigel DR |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Jan 1. pii: 10.1200/jco.2011.29.15_suppl.lba7512 |
| PMID: 28020760 |
| Oxaliplatin, irinotecan, and bevacizumab followed by docetaxel and bevacizumab in inoperable gastric cancer: First results of a multicenter phase II trial (AGMT Gastric-3) of the Arbeitsgemeinschaft Medikamentoese Tumortherapie (AGMT). |
| Woell E, Keil F, Thaler J, Gruenberger B, Hejna M, Eisterer W, Fridrik MA, Romeder F, Greil R |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Jan 1. pii: 10.1200/jco.2011.29.15_suppl.e14502 |
| PMID: 28020630 |
| Impact of the type and modalities of preoperative chemotherapy on the outcome of liver resection for colorectal metastases. |
| Adam R, Barroso E, Laurent C, Nuzzo G, Hubert C, Mentha G, Ijzermans J, Capussotti L, Lopezben S, Mirza D, Kaiser G, Oussoultzoglou E, Gruenberger T, Poston GJ, Skipenko O |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Jan 1. pii: 10.1200/jco.2011.29.15_suppl.3519 |
| PMID: 28020338 |
| Cetuximab weekly (q1w) versus every two weeks (q2w) plus FOLFOX4 as first-line therapy in patients (pts) with KRAS wild-type (wt) metastatic colorectal cancer (mCRC). |
| Ciuleanu T, Nikolic V, Shmueli E, Vrbanec D, Plate S, Krmpotic ZM, Dank M, Purkalne G, Brodowicz T, Zielinski C |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Jan 1. pii: 10.1200/jco.2011.29.15_suppl.3580 |
| PMID: 28020239 |
| Clinical outcome of GBM long-term survivors. |
| Flechl B, Ackerl M, Sax C, Dieckmann K, Crevenna R, Widhalm G, Preusser M, Marosi C |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Jan 1. pii: 10.1200/jco.2011.29.15_suppl.e12507 |
| PMID: 28020016 |
| A phase Ib/II open-label study to evaluate the safety and efficacy of TRU-016 in combination with bendamustine versus bendamustine alone in patients with relapsed chronic lymphocytic leukemia. |
| Awan FT, Pagel JM, Goy A, Rifkin RM, Poiesz BJ, Mato AR, Stromatt SC, Byrd JC, Jaeger U |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Jan 1. pii: 10.1200/jco.2011.29.15_suppl.e13053 |
| PMID: 28019874 |
| Randomized comparison of VAC versus VAI chemotherapy (CT) as consolidation for standard risk (SR) Ewing sarcoma tumor (ES): Results of the Euro-EWING.99-R1 trial. |
| Oberlin O, Le Deley M, Dirksen U, Lewis IJ, Ranft A, Michon JM, Paulussen M, Whelan J, Ladenstein RL, Brennan B, Marec Bérard P, Laurence V, Van Den Berg H, Hjorth L, Douglas C, Wheatley K, Van Glabbeke MM, Judson IR, Craft AW, Juergens H |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Jan 1. pii: 10.1200/jco.2011.29.15_suppl.9517 |
| PMID: 28019807 |
| The prognostic value of semi-quantitative (123)I mIBG scintigraphy at diagnosis in high-risk neuroblastoma: Validation of the SIOPEN score method. |
| Lewington V, Poetschger U, Boubaker A, Bar-Sever Z, Drake B, Staudenherz A, Castellani MR, Lambert B, Grange K, Brock P, Garaventa A, Yaniv I, Valteau Couanet D, Castel V, Forjaz De Lacerda A, Malis J, Schroeder H, Luksch R, Beiske K, Ladenstein RL |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Jan 1. pii: 10.1200/jco.2011.29.15_suppl.9511 |
| PMID: 28019804 |
| A detailed dosimetric comparison between manual and inverse plans in HDR intracavitary/interstitial cervical cancer brachytherapy. |
| Trnková P, Baltas D, Karabis A, Stock M, Dimopoulos J, Georg D, Pötter R, Kirisits C |
| Journal of contemporary brachytherapy. doi: 10.5114/jcb.2010.19497. pii: 16095 |
| PMID: 27853479 |
| Differential expression pattern of estrogen receptors, aromatase, and sulfotransferase in breast cancer tissue and corresponding lymph node metastases. |
| Gschwantler-Kaulich D, Fink-Retter A, Czerwenka K, Hudelist G, Kaulich A, Kubista E, Singer CF |
| Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2010 Dec 29. doi: 10.1007/s13277-010-0144-3 |
| PMID: 21188569 |
| Angioarchitectural heterogeneity in human glioblastoma multiforme: a fractal-based histopathological assessment. |
| Di Ieva A, Grizzi F, Sherif C, Matula C, Tschabitscher M |
| Microvascular research. 2010 Dec 28. pii: S0026-2862(10)00263-3. doi: 10.1016/j.mvr.2010.12.006 |
| PMID: 21192955 |
| Reconstitution of human MCF-7 breast cancer cells with caspase-3 does not sensitize them to action of CDK inhibitors. |
| Węsierska-Gądek J, Hackl S, Zulehner N, Maurer M, Komina O |
| Journal of cellular biochemistry. 2010 Dec 27. doi: 10.1002/jcb.22918 |
| PMID: 21080333 |
| Hepatocellular carcinoma: the place of new medical therapies. |
| Peck-Radosavljevic M |
| Therapeutic advances in gastroenterology. 2010 Dec 24. doi: 10.1177/1756283X10362278. pmc: PMC3002584 |
| PMID: 21180607 |
| Cross-resistance of 5-fluorouracil-resistant colon carcinoma in vitro. |
| Ratzenboeck IE, Bartl B, Forstner B, Kalipciyan M, Steger GG, Mader RM |
| International journal of clinical pharmacology and therapeutics. 2010 Dec 23. pii: 8276 |
| PMID: 21176738 |
| Suicide activation in a 5-fluorouracil resistant colon cancer model in vitro. |
| Mader RM, Kalipciyan M, Ohana P, Hochberg A, Steger GG |
| International journal of clinical pharmacology and therapeutics. 2010 Dec 23. pii: 8271 |
| PMID: 21176733 |
| Relevance of microRNA modulation in chemoresistant colon cancer in vitro. |
| Mader RM, Wieser M, Berger W, Kalipciyan M, Hackl M, Steger GG, Grillari J |
| International journal of clinical pharmacology and therapeutics. 2010 Dec 23. pii: 8270 |
| PMID: 21176732 |
| CXCL9 induces chemotaxis, chemorepulsion and endothelial barrier disruption through CXCR3-mediated activation of melanoma cells. |
| Amatschek S, Lucas R, Eger A, Pflueger M, Hundsberger H, Knoll C, Grosse-Kracht S, Schuett W, Koszik F, Maurer D, Wiesner C |
| British journal of cancer. 2010 Dec 21. pii: 6606056. doi: 10.1038/sj.bjc.6606056. pmc: PMC3049560 |
| PMID: 21179030 |
| Feasibility of CBCT-based target and normal structure delineation in prostate cancer radiotherapy: multi-observer and image multi-modality study. |
| Lütgendorf-Caucig C, Fotina I, Stock M, Pötter R, Goldner G, Georg D |
| Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2010 Dec 20. pii: S0167-8140(10)00719-X. doi: 10.1016/j.radonc.2010.11.016 |
| PMID: 21176984 |
| Prevention of bone metastases and management of bone health in early breast cancer. |
| Gnant M, Hadji P |
| Breast cancer research : BCR. 2010 Dec 17. pii: bcr2768. doi: 10.1186/bcr2768. pmc: PMC3046430 |
| PMID: 21172067 |
| 21411 Einträge | « ‹ 863, 864, 865, 866, 867, 868, 869, 870, 871, 872, 873, 874, 875, 876, 877, 878, 879, 880, 881 › » |
Seite 872 / 1071
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
